PDG21 THE GENERIC ENTRY AND MARKET SHARE COMPETITION OF STATINS MEDICATION USE: A RETROSPECTIVE TREND ANALYSIS OF UTILIZATION, SPENDING, AND PRICES IN THE UNITED STATES MEDICAID PROGRAMS FROM 1991 TO 2017
May 1, 2020, 00:00
10.1016/j.jval.2020.04.311
https://www.valueinhealthjournal.com/article/S1098-3015(20)30499-X/fulltext
Title :
PDG21 THE GENERIC ENTRY AND MARKET SHARE COMPETITION OF STATINS MEDICATION USE: A RETROSPECTIVE TREND ANALYSIS OF UTILIZATION, SPENDING, AND PRICES IN THE UNITED STATES MEDICAID PROGRAMS FROM 1991 TO 2017
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30499-X&doi=10.1016/j.jval.2020.04.311
First page :
Section Title :
Open access? :
No
Section Order :
10178